Version
STING Agonist 8803 Reprograms the Immune Microenvironment and Increases Survival in Preclinical Models of Glioblastoma
CTSA https://pubmed.ncbi.nlm.nih.gov/38941297/ 2024-06-17T00:00:00Z The Journal of Clinical Investigation